GENYO at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

GENYO brings 3 presentations to ISLB 2026 in Madrid. Its work covers circulating tumour cells and tumour DNA during cancer therapy, and how cell-free DNA is extracted for testing. One study tracks how tumour cells and tumour DNA change during PARP inhibitor therapy in ovarian cancer, and another compares two automated extraction methods in early colorectal cancer.

OrganizationISLB 2026 Attendance
GENYO
Granada, Spain
Universities & research institutes
Genomics and oncology research centre run jointly by Pfizer, the University of Granada and the Andalusian regional government.
Talk
Sun Nov 8
5:30pm–6:30pm
Summary of ISLB YC 2026 Activities

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from GENYO

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction